Ovid Therapeutics Inc. Appoints Kevin Norrett as Chief Business Officer and Promotes Charles Carter to CFO
Position
Chief Financial Officer
Company
Ovid Therapeutics
New YorkBiotechnologyHealthcareHealth CareTherapeuticsDescription
On July 8, 2026, Ovid Therapeutics Inc. announced the appointment of Kevin Norrett as chief business officer and promoted Charles Carter to CFO. Norrett will lead business development and partnerships while Carter will head business and financial operations.
Quick answer
Ovid Therapeutics Inc. Appoints Kevin Norrett as Chief Business Officer and Promotes Charles Carter to CFO (July 14, 2026). Ovid Therapeutics is based in New York, New York, United States.
- Who is the new Chief Financial Officer at Ovid Therapeutics?
- Ovid Therapeutics named Charles Carter Chief Financial Officer, announced July 14, 2026.
- What did Ovid Therapeutics announce on July 14, 2026?
- On July 8, 2026, Ovid Therapeutics Inc. announced the appointment of Kevin Norrett as chief business officer and promoted Charles Carter to CFO. Norrett will lead business development and partnerships while Carter will head business and financial operations.
- What does Ovid Therapeutics do?
- Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions.
- Where is Ovid Therapeutics based?
- Ovid Therapeutics is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- EyePoint, Inc. (July 14, 2026), Sarepta Therapeutics (July 27, 2026), Korsana Biosciences (August 3, 2026) and Olema Oncology, Inc. (August 13, 2026) also announced leadership changes within 45 days of Ovid Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- EyePoint Appoints Tarek S. Hassan as Senior Vice President, Chief Strategic Science Officer (July 14, 2026)
- Sarepta Therapeutics Appoints Michael Severino as Chief Executive Officer (July 27, 2026)
- Korsana Biosciences Appoints Matthew Leoni as Chief Medical Officer and Gan Wei as Chief Technical Officer (August 3, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Avalon Appoints Sam Knipper as Chief Financial Officer (June 4, 2026)
- Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer (June 3, 2026)
Who to call at Ovid Therapeutics, and when
A new leader at Ovid Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ovid Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ovid Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ovid Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ovid Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ovid Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.